|
1
|
Kiss S, Leiderman YI and Mukai S:
Diagnosis, classification, and treatment of retinoblastoma. Int
Ophthalmol Clin. 48:135–147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu Q, Wang Y, Wang H, Liu Y, Liu T and
Kunda PE: Tandem therapy for retinoblastoma: Immunotherapy and
chemotherapy enhance cytotoxicity on retinoblastoma by increasing
apoptosis. J Cancer Res Clin Oncol. 139:1357–1372. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shields CL and Shields JA: Basic
understanding of current classification and management of
retinoblastoma. Curr Opin Ophthalmol. 17:228–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Moura LR, Marshall JC, Di Cesare S,
Fernandes BF, Antecka E and Burnier MN: The effect of imatinib
mesylate on the proliferation, invasive ability, and
radiosensitivity of retinoblastoma cell lines. Eye (Lond).
27:92–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chawla B, Hasan F, Azad R, Seth R,
Upadhyay AD, Pathy S and Pandey RM: Clinical presentation and
survival of retinoblastoma in Indian children. Br J Ophthalmol.
100:172–178. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dunkel IJ, Khakoo Y, Kernan NA, Gershon T,
Gilheeney S, Lyden DC, Wolden SL, Orjuela M, Gardner SL and
Abramson DH: Intensive multimodality therapy for patients with
stage 4a metastatic retinoblastoma. Pediatr Blood Cancer. 55:55–59.
2010.PubMed/NCBI
|
|
7
|
Dong JT, Lamb PW, RinkerSchaeffer CW,
Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC: KAI1, a
metastasis suppressor gene for prostate cancer on human chromosome
11p11.2. Science. 268:884–886. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park JJ, Jin YB, Lee YJ, Lee JS, Lee YS,
Ko YG and Lee M: KAI1 suppresses HIF-1α and VEGF expression by
blocking CDCP1-enhanced Src activation in prostate cancer. BMC
Cancer. 12:812012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee HA, Park I, Byun HJ, Jeoung D, Kim YM
and Lee H: Metastasis suppressor KAI1/CD82 attenuates the matrix
adhesion of human prostate cancer cells by suppressing fibronectin
expression and β1 integrin activation. Cell Physiol Biochem.
27:575–586. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gellersen B, Wolf A, Kruse M, Schwenke M
and Bamberger AM: Human endometrial stromal cell-trophoblast
interactions: Mutual stimulation of chemotactic migration and
promigratory roles of cell surface molecules CD82 and CEACAM1. Biol
Reprod. 88:802013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng J, Huang C, Wren JD, Wang DW, Yan J,
Zhang J, Sun Y, Han X and Zhang XA: Tetraspanin CD82: A suppressor
of solid tumors and a modulator of membrane heterogeneity. Cancer
Metastasis Rev. 34:619–633. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bouras T and Frauman AG: Expression of the
prostate cancer metastasis suppressor gene KAI1 in primary prostate
cancers: A biphasic relationship with tumour grade. J Pathol.
188:382–388. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mooez S, Malik FA, Kayani MA, Rashid R,
Zahid A and Khan A: Expressional alterations and transcript
isoforms of metastasis suppressor genes (KAI1 and KiSS1) in breast
cancer patients. Asian Pac J Cancer Prev. 12:2785–2791.
2011.PubMed/NCBI
|
|
14
|
Friess H, Guo XZ, BeRBerat P, Graber HU,
Zimmermann A, Korc M and Büchler MW: Reduced KAI1 expression in
pancreatic cancer is associated with lymph node and distant
metastases. Int J Cancer. 79:349–355. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shiwu WU, Lan Y, Wenqing S, Lei Z and
Yisheng T: Expression and clinical significance of CD82/KAI1 and
E-cadherin in non-small cell lung cancer. Arch Iran Med.
15:707–712. 2012.PubMed/NCBI
|
|
16
|
Lakshmi S Amirtha, Pushparaj V,
Krishnamurthy V, Biswas J, Krishnakumar S and Shanmugam MP:
Tetraspanin protein KAI1 expression in retinoblastoma. Br J
Ophthalmol. 88:593–595. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C (T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ji X, Zhang J, Cheng L, Wei F, Li H, Liu
X, Chen X, Li C, Wang Y and Huang Q: Oncolytic adenovirus
delivering herpes simplex virus thymidine kinase suicide gene
reduces the growth of human retinoblastoma in an in vivo mouse
model. Exp Eye Res. 89:193–199. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu H, Wang C, Zhu H, Liu S, Xu X and Jiang
Y: Characteristics of an established retinoblastoma cell line
HXO-Rb44. Yan Ke Xue Bao. 11:16–21. 1995.PubMed/NCBI
|
|
20
|
Lv K, Guo Y, Zhang Y, Wang K, Li K, Zhu Y
and Sun S: Transient inhibition of foot-and-mouth disease virus
replication by siRNAs silencing VP1 protein coding region. Res Vet
Sci. 86:443–452. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li M, Husic N, Lin Y and Snider BJ:
Production of lentiviral vectors for transducing cells from the
central nervous system. J Vis Exp. 24:e40312012.
|
|
22
|
Ji XD, Yan H and Zhao PQ: Expression
changes of tumor metastasis-related genes after overexpression of
KAI1 in retinoblastoma Y79 cells. Zhonghua Yan Ke Za Zhi.
48:1097–1101. 2012.(In Chinese). PubMed/NCBI
|
|
23
|
Zhang B, Liu W, Li L, Lu J, Liu M, Sun Y
and Jin D: KAI1/CD82 and Cyclin D1 as biomarkers of invasion,
metastasis and prognosis of laryngeal squamous cell carcinoma. Int
J Clin Exp Pathol. 6:1060–1067. 2013.PubMed/NCBI
|
|
24
|
Yang X, Wei LL, Tang C, Slack R, Mueller S
and Lippman ME: Overexpression of KAI1 suppresses in vitro
invasiveness and in vivo metastasis in breast cancer cells. Cancer
Res. 61:5284–5288. 2001.PubMed/NCBI
|
|
25
|
Xu JH, Guo XZ, Ren LN, Shao LC and Liu MP:
KAI1 is a potential target for anti-metastasis in pancreatic cancer
cells. World J Gastroenterol. 14:1126–1132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ruseva Z, Geiger PX, Hutzler P, Kotzsch M,
Luber B, Schmitt M, Gross E and Reuning U: Tumor suppressor KAI1
affects integrin alphavbeta3-mediated ovarian cancer cell adhesion,
motility, and proliferation. Exp Cell Res. 315:1759–1771. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lombardi DP, Geradts J, Foley JF, Chiao C,
Lamb PW and Barrett JC: Loss of KAI1 expression in the progression
of colorectal cancer. Cancer Res. 59:5724–5731. 1999.PubMed/NCBI
|
|
28
|
Stark AM, Tongers K, Maass N, Mehdorn HM
and Held-Feindt J: Reduced metastasis-suppressor gene
mRNA-expression in breast cancer brain metastases. J Cancer Res
Clin Oncol. 131:191–198. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Malik FA, Sanders AJ, Kayani MA and Jiang
WG: Effect of expressional alteration of KAI1 on breast cancer cell
growth, adhesion, migration and invasion. Cancer Genomics
Proteomics. 6:205–213. 2009.PubMed/NCBI
|
|
30
|
Liu X, Guo XZ, Zhang WW, Lu ZZ, Zhang QW,
Duan HF and Wang LS: KAI1 inhibits HGF-induced invasion of
pancreatic cancer by sphingosine kinase activity. Hepatobiliary
Pancreat Dis Int. 10:201–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang JM, Peng ZH, Si SH, Liu WW, Luo YH
and Ye ZY: KAI1 gene suppresses invasion and metastasis of
hepatocellular carcinoma MHCC97-H cells in vitro and in animal
models. Liver Int. 28:132–139. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu WM and Zhang XA: KAI1/CD82, a tumor
metastasis suppressor. Cancer Lett. 240:183–194. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Miranti CK: Controlling cell surface
dynamics and signaling: How CD82/KAI1 supresses metastasis. Cell
Signal. 21:196–211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Abe M, Sugiura T, Takahashi M, Ishii K,
Shimoda M and Shirasuna K: A novel function of CD82/KAI-1 on
E-cadherin-mediated homophilic cellular adhesion of cancer cells.
Cancer Lett. 266:163–170. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
